Description

Buy regenon retard 60 mg capsule

Regenon retard 60 mg capsule (Amfepramon) helps to reduce body weight . You can buy Regenon amfepramona 60 mg capsules if you want Los weight faster.

What is Regenon?
Regenon, also known as Tenuate, is a drug from the appetite suppressant group. The active ingredient diethylpropion contained in Regenon makes you feel less hungry. You can order Regenon online from one of the pharmacies that work with

Amfepramone 60 mg
Amfepramone, also known as diethylpropion, is a stimulant drug of the phenethylamine, amphetamine, and cathinone classes that is used as an appetite suppressant. It is used in the short-term management of obesity, along with dietary and lifestyle changes.

Indications
Obesity of nutritional origin.

As part of combination therapy – adiposogenital syndrome, hypothyroidism.

Dosage regimen
It is taken orally at 25 mg 2-3 times / day 30-60 minutes before meals in combination with a low-calorie diet; with insufficient effect – 100 mg / day. The course of treatment is 6-10 weeks; repeated course – after 3 months.

Children over 12 years of age are prescribed half the dose of adults.

How do you take Regenon (Tenuate) correctly?
Always take Regenon on a low-calorie diet and try to exercise more at the same time. This is the only way to lose weight. Regenon is usually prescribed as a cure for a few weeks.

This medicine is not suitable for long use. Take the regular tablet as a whole with plenty of water about an hour before a meal. Do not take the tablet shortly before going to bed, the active ingredient Regenon (Tenuate) can make it difficult to fall asleep. If you take the tablet with the “extended release coating” (long-term effect), you only have to swallow one tablet once a day.

This should be done in the morning. Please adhere to the prescribed dosage. If you want to stop taking Regenon, you should slowly reduce the dosage, to avoid withdrawal symptoms. A doctor can give you more details. Do not lose weight even though you are taking Regenon (Tenuate) and following the dietary advice, please consult a doctor.

Side effect
From the cardiovascular system: tachycardia, increased blood pressure.

From the side of the central nervous system: weakness, headache, insomnia, euphoria, irritability, worsening of mood.

From the digestive system: dry mouth, nausea, vomiting, constipation or diarrhea.

Allergic reactions: rash, itching, swelling of the eyelids, rhinitis, conjunctivitis.

Regenon retard 60 mg

Regenon retard 60 mg considered to produce less central nervous system disturbance for patients with hypertension.

1 capsule contains: Active ingredient: 25 mg Amfepramoni hydrochloridum (INN prop.).
Excipient: Ethylvanillinum.
Regenon delay 1 tablet contains: Active ingredient: 75 mg Amfepramoni hydrochloridum (INN prop.).

Ingredient matches for Regenon retard

Amfepramone

Amfepramone hydrochloride (a derivative of Amfepramone) is reported as an ingredient of Regenon retard in the following countries:

• Germany
• Romania

Foreign Names

• Amfepramonum (Latin)
• Amfepramon (German)
• Amfépramone (French)
• Anfepramona (Spanish)

Chemical Names

1-Propanone, 2-(dietylamino)-1-phenyl-

2-(Dietylamino)propiophenone (WHO)

2-Dietylaminopropiophenon (IUPAC)

Properties / Effects

Regenon and Regenon retard 60 mg contain a substance with a central stimulating effect which also has an anorectic effect, among other things.

Employment limitations

Cons-indications
– Hypersensitivity to one of the components of Regenon or Regenon retard.
– Pregnancy and breast feeding.
– Severe high blood pressure.
– Pulmonary arterial hypertension.
– History or existence of cerebrovascular or cardiovascular diseases, including heart rhythm disturbances.
– Tendency to drug abuse, declared alcoholism.
– Children under the age of 12.
– History or existence of mental illnesses, including nervous anorexia and depression.
– Hyperthyroidism, pheochromocytoma, glaucoma, prostatic hyperplasia, hepatic and renal insufficiency.
– Cannot be taken at the same time as MAO inhibitors or during the 2 weeks after the interruption of such treatment.
Concomitant treatment with another centrally acting appetite suppressant is contraindicated, in particular because of the increased risk of pulmonary hypertension with possible lethal outcome and the possible risk of damage to the heart valves.